News
STUTTGART, Germany I July 24, 2025 I La Merie Publishing released its newest product entitled: Folate Receptor alpha (FRα) Targeted Therapy: a Competitor ...
CAMBRIDGE, MA, USA I July 23, 2025 I Apnimed, Inc., a pharmaceutical company advancing an industry-leading pipeline of first-in-class oral therapies that ...
MENLO PARK, CA, USA & GENEVA, Switzerland I July 23, 2025 I AN2 Therapeutics, Inc. (Nasdaq: ANTX) and the non-profit medical research organization Drugs ...
Landmark approval is based on results from the Phase 3 AQUILA study, showing fixed-duration treatment with daratumumab significantly reduced the risk of ...
BASEL, Switzerland I July 23, 2025 I Windward Bio AG, a private, clinical-stage biotechnology company committed to improving outcomes for people living with ...
HENNIGSDORF / BERLIN, Germany I July 23, 2025 I 4TEEN4 Pharmaceuticals GmbH today announced that the first patient has been dosed in a Phase 1b/2a PROCARD1 ...
HONG KONG, China I July 23, 2025 I Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been enrolled in the ...
First-in-class Flare platform designed to address targeting and resistance mechanisms in solid tumors to expand curative potential of immunotherapies for ...
HOUSTON, TX, USA I July 23, 2025 I InGeneron, Inc., a biotechnology company pioneering autologous regenerative cell therapies, today announced the publication ...
BALLERUP, Denmark I July 23, 2025 I LEO Pharma, a global leader in medical dermatology, announced today that the U.S. Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results